Reuters logo
3 个月前
BRIEF-Spring Bank Pharmaceuticals posts Q1 loss per share $0.69
2017年4月28日 / 下午1点20分 / 3 个月前

BRIEF-Spring Bank Pharmaceuticals posts Q1 loss per share $0.69

1 分钟阅读

April 28 (Reuters) - Spring Bank Pharmaceuticals Inc

* Spring Bank Pharmaceuticals provides corporate update and reports first quarter 2017 financial and operational results

* Q1 loss per share $0.69

* Spring Bank Pharmaceuticals Inc - cash, cash equivalents and marketable securities were $21.1 million as of March 31, 2017

* Spring Bank Pharma - anticipates existing cash, cash equivalents will enable it to fund operating expenses and capex requirements into Q3 of 2018

* Spring Bank Pharmaceuticals - remains on track and anticipates reporting top-line results from SB 9200 25mg monotherapy dosing cohort in Q2 of 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below